スポンサーリンク
Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research | 論文
- A Pilot Study of Wider Use of Accelerated Partial Breast Irradiation : Intraoperative Margin-directed Re-excision Combined with Sole High-dose-rate Interstitial Brachytherapy
- Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia : Study of the Japan Adult Leukemia Study Group (JALSG)
- Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer : Japan Clinical Oncology Group study, JCOG 9208
- Case-control study of leukemia and diagnostic radiation exposure
- Efficacy and Safety of Imatinib Mesylate for Patients in the First Chronic Phase of Chronic Myeloid Leukemia : Results of a Japanese Phase II Clinical Study
- Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
- Preliminary Study of Correction of Original Metal Artifacts due to I-125 Seeds in Postimplant Dosimetry for Prostate Permanent Implant Brachytherapy
- Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
- Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
- Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
- Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
- High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
- Severe Infusion Reaction Induced by Trastuzumab : A Case Report
- Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
- Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
- Assessment of hormone receptor status in breast cancer
- Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
- Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways